BR9608626A - Peptédeo preparação farmacéutica e uso de um peptídeo - Google Patents

Peptédeo preparação farmacéutica e uso de um peptídeo

Info

Publication number
BR9608626A
BR9608626A BR9608626A BR9608626A BR9608626A BR 9608626 A BR9608626 A BR 9608626A BR 9608626 A BR9608626 A BR 9608626A BR 9608626 A BR9608626 A BR 9608626A BR 9608626 A BR9608626 A BR 9608626A
Authority
BR
Brazil
Prior art keywords
peptide
cells
pharmaceutical preparation
autoimmune diseases
articular cartilage
Prior art date
Application number
BR9608626A
Other languages
English (en)
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR9608626A publication Critical patent/BR9608626A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR9608626A 1995-06-19 1996-06-17 Peptédeo preparação farmacéutica e uso de um peptídeo BR9608626A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95201656 1995-06-19
PCT/EP1996/002605 WO1997000270A1 (en) 1995-06-19 1996-06-17 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases

Publications (1)

Publication Number Publication Date
BR9608626A true BR9608626A (pt) 1999-06-15

Family

ID=8220392

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608626A BR9608626A (pt) 1995-06-19 1996-06-17 Peptédeo preparação farmacéutica e uso de um peptídeo

Country Status (21)

Country Link
EP (1) EP0833842B1 (pt)
JP (1) JPH11507919A (pt)
KR (1) KR19990022972A (pt)
CN (1) CN1155617C (pt)
AT (1) ATE185151T1 (pt)
AU (1) AU704942B2 (pt)
BR (1) BR9608626A (pt)
CA (1) CA2221981A1 (pt)
DE (1) DE69604492T2 (pt)
DK (1) DK0833842T3 (pt)
ES (1) ES2139363T3 (pt)
GR (1) GR3031990T3 (pt)
HU (1) HU223275B1 (pt)
IL (1) IL118524A (pt)
MX (1) MX9710508A (pt)
NO (1) NO975968D0 (pt)
NZ (1) NZ311022A (pt)
PL (1) PL185258B1 (pt)
TR (1) TR199701658T1 (pt)
WO (1) WO1997000270A1 (pt)
ZA (1) ZA965163B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MEP42108A (en) 1998-10-23 2011-02-10 Kiren Amgen Inc Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
IL132611A0 (en) * 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US7541184B2 (en) 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
WO2006036834A2 (en) 2004-09-24 2006-04-06 Amgen Inc. MODIFIED Fc MOLECULES
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
CN112996801A (zh) * 2018-11-26 2021-06-18 北卡罗来纳州大学 用于捕获宿主细胞蛋白的肽配体

Also Published As

Publication number Publication date
ZA965163B (en) 1997-01-23
KR19990022972A (ko) 1999-03-25
NO975968L (no) 1997-12-18
TR199701658T1 (xx) 1998-06-22
PL185258B1 (pl) 2003-04-30
PL324208A1 (en) 1998-05-11
ES2139363T3 (es) 2000-02-01
HU223275B1 (hu) 2004-04-28
GR3031990T3 (en) 2000-03-31
DE69604492D1 (de) 1999-11-04
DK0833842T3 (da) 2000-04-03
CA2221981A1 (en) 1997-01-03
MX9710508A (es) 1998-03-31
CN1188483A (zh) 1998-07-22
IL118524A (en) 2004-02-19
AU6224696A (en) 1997-01-15
NZ311022A (en) 1999-11-29
AU704942B2 (en) 1999-05-06
NO975968D0 (no) 1997-12-18
EP0833842B1 (en) 1999-09-29
HUP9802197A2 (hu) 1999-02-01
WO1997000270A1 (en) 1997-01-03
EP0833842A1 (en) 1998-04-08
ATE185151T1 (de) 1999-10-15
CN1155617C (zh) 2004-06-30
DE69604492T2 (de) 2000-04-13
IL118524A0 (en) 1996-09-12
HUP9802197A3 (en) 1999-06-28
JPH11507919A (ja) 1999-07-13

Similar Documents

Publication Publication Date Title
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
BR9506377A (pt) Peptídeo compreendendo uma subsequéncia de gp-39 hc proteina gp-39 hc ou peptideos composição farmacéutica uso da proteina gp-39 hc ou um ou mais dos peptídeos composição de diagnostico e processo de diagnóstico e kit de teste para a detecção de céçiças t auto-reativas ativadas
NZ332427A (en) Peptides suitable for use in antigen specific immunosuppressive therapy
TR199802082T2 (xx) Otoantigen ve otoim�n hastal�klar�n im�noterapisinde kullan�lmak i�in otoantigen yap�sal olarak ili�kili proteinler.
BR9608626A (pt) Peptédeo preparação farmacéutica e uso de um peptídeo
ATE442439T1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
PT1025849E (pt) Metodos para deteccao e tratamento de individuos tendo celulas anormais que expressam antigenios do peptideo hla-a2/tirosinase
ZA943920B (en) Pharmaceutical compositions
TR200100175T2 (tr) Otoimmün hastalıkların immünoterapisinde kullanılmak üzere yeni peptitler.
EA200001127A1 (ru) Бактериальные феромоны и их использование
BR9811250A (pt) Peptìdeos compreendendo uma epìtopo de célula t, especìfica para colágeno ii
IT1283899B1 (it) Peptidi e loro usi nella terapia della malattia celiaca
DE69631624D1 (de) Antikörper gegen menschliches restrictin
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
ECSP993062A (es) Nuevos peptidos para ser usados en una terapia de tolerancia inducida para impedir las alteraciones autoinmunes, en particular, artritis reumatoidea
ES2193601T3 (es) Utilizacion de peptidos de citrulina derivados a la filagrina en el marco del tratamiento de enfermedades autoinmunes.
BR0112339A (pt) Polinucleotìdeo que codifica um polipeptìdeo, vetor de expressão recombinante, polipeptìdeo, composição farmacêutica, uso do polipeptìdeo célula, uso de um dna ou de um vetor de expressão, ou de uma célula ou de um polipeptìdeo, método para identificar peptìdeos tolerogênicos, método para a formulação de um composição farmacêutica, uso de um peptìdeo, composição de diagnóstico, e, método de diagnóstico e conjunto de teste para a detecção de células t autorreativas ativadas

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements